Development of Novel ImmunoPET Tracers to Image Human PD-1 Checkpoint Expression on Tumor-Infiltrating Lymphocytes in a Humanized Mouse Model.
about
Clinical characteristics of patient selection and imaging predictors of outcome in solid tumors treated with checkpoint-inhibitors.Dosimetry Prediction for Clinical Translation of 64Cu-Pembrolizumab ImmunoPET Targeting Human PD-1 Expression.Incorporating Radiation Oncology into Immunotherapy: proceedings from the ASTRO-SITC-NCI immunotherapy workshop.Biomarkers for Clinical Benefit of Immune Checkpoint Inhibitor Treatment-A Review From the Melanoma Perspective and BeyondRole of noninvasive molecular imaging in determining response
P2860
Development of Novel ImmunoPET Tracers to Image Human PD-1 Checkpoint Expression on Tumor-Infiltrating Lymphocytes in a Humanized Mouse Model.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Development of Novel ImmunoPET ...... es in a Humanized Mouse Model.
@en
Development of Novel ImmunoPET ...... es in a Humanized Mouse Model.
@nl
type
label
Development of Novel ImmunoPET ...... es in a Humanized Mouse Model.
@en
Development of Novel ImmunoPET ...... es in a Humanized Mouse Model.
@nl
prefLabel
Development of Novel ImmunoPET ...... es in a Humanized Mouse Model.
@en
Development of Novel ImmunoPET ...... es in a Humanized Mouse Model.
@nl
P2093
P2860
P1476
Development of Novel ImmunoPET ...... es in a Humanized Mouse Model.
@en
P2093
Aaron T Mayer
Arutselvan Natarajan
Claude M Nagamine
Robert E Reeves
Sanjiv Sam Gambhir
P2860
P2888
P304
P356
10.1007/S11307-017-1060-3
P577
2017-02-28T00:00:00Z